INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2009

Regular sunscreen use may prevent actinic keratoses and invasive squamous cell carcinomas in organ transplant recipients.

A 24-month prospective study evaluated 120 matched organ transplant recipients where 60 patients received free broad-spectrum sunscreen (SPF>50) for daily application alongside standard sun protection advice given to all participants. Over 24 months, 8 new invasive SCCs occurred in the control group versus 0 in the sunscreen group (P<0.01), and new AK counts differed significantly (-102 in sunscreen group vs. +82 in controls; P<0.01). BCC occurrences were 2 in the sunscreen group versus 9 in controls (not significant). Serum 25(OH)D levels were lower in the sunscreen group than controls (mean 53 ng mL(-1) vs. 60 ng mL(-1)).

Study type
Prospective, matched controlled study
Who was studied
120 matched organ transplant recipients (40 heart, 40 kidney, 40 liver)
What was measured
New actinic keratoses (AK), invasive squamous cell carcinomas (SCC), basal cell carcinomas (BCC), and serum 25(OH)D levels

THE PAPER

Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.

Ulrich C, Jürgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, Eberle J, Terhorst D, Sterry W, Stockfleth E. Br J Dermatol, 2009.

PubMed 19775361 ↗DOI 10.1111/j.1365-2133.2009.09453.x ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.